Search
for

    Sort by

    Research 361–390 of 1000+

    1. Role of Non Androgenic Factors in Hair loss and Hair Regrowth Journal of cosmetology & trichology · 2017 · 7 citations
    2. Cell Therapy for Androgenetic Alopecia: Elixir or Trick? Stem cell reviews and reports · 2023
    3. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa Yearbook of Dermatology and Dermatologic Surgery · 2009
    4. Impulse Control Disorders ˜The œjournal of nervous and mental disease · 2012
    5. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia Journal of The American Academy of Dermatology · 2011 · 81 citations
    6. Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study International Journal of Dermatology · 2018 · 49 citations
    7. Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia Dermatologic Surgery · 2016 · 4 citations
    8. An Integrative Approach of Neeli Bhringraj Polyherbal Hair Oil in Clinical Evaluation of Androgenetic Alopecia (Khalitya) and Premature Hair Graying (Pālitya): A Randomized, Double-Blind Clinical Study Cureus · 2026
    9. <i>Curcuma aeruginosa</i>, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study Journal of Dermatological Treatment · 2011 · 34 citations
    10. Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA) SKIN The Journal of Cutaneous Medicine · 2025
    11. A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia 2012
    12. Supplementary Material for: Sesquiterpene-Enriched Extract of <i>Curcuma aeruginosa</i> Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study Figshare · 2018
    13. Double-blind randomized placebo-controlled study of the efficacy and safety of hair loss prevention shampoo containing salicylic acid, panthenol, and niacinamide in alopecia patients Toxicology and Environmental Health Sciences · 2022 · 1 citations
    14. [Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author’s transl)]. PubMed · 1980 · 37 citations
    15. A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine Cosmetics · 2023 · 2 citations
    16. A multi-centre, double-blind, randomised, vehicle-controlled study for a quantitative estimation of hair re-growth in male subjects with androgenetic alopecia treated over 6 month with two ethanolic PSK 3841 solutions (2.5% and 5%) 2012
    17. [Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method--with special reference to hair loss]. PubMed · 1983 · 6 citations
    18. The efficacy of subcutaneous slow‐release melatonin implants in the prevention of canine flank alopecia recurrence is uncertain: A double‐blind, randomized, placebo‐controlled study Veterinary Dermatology · 2022 · 3 citations
    19. Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2016
    20. Skin and Scalp Health Benefits of a Specific Botanical Extract Blend: Results from a Double-Blind Placebo-Controlled Study in Urban Outdoor Workers Cosmetics · 2024 · 3 citations
    21. An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo‐controlled, double blind intervention study Health science reports · 2023
    22. Antihirsutism activity of Fennel (fruits of Foeniculum vulgare) extract – A double-blind placebo controlled study Phytomedicine · 2003 · 59 citations
    23. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial Frontiers in Medicine · 2021 · 42 citations
    24. A randomized, double blind, placebo controlled, split patch study to evaluate the effects of platelet rich plasma on alopecia areata International Journal of Research in Medical Sciences · 2018
    25. Faculty Opinions recommendation of A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2011
    26. Faculty Opinions recommendation of Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2014
    27. Comparison of single-spin to double-spin platelet-rich plasma centrifugation methods in the treatment of androgenic alopecia: a systematic review and meta-analysis of randomized controlled trials Frontiers in Medicine · 2025
    28. Effect of platelet counts and activator in platelet-rich plasma on the treatment of androgenetic alopecia, split-head comparison: A randomised, double-blind study Indian Journal of Dermatology, Venereology and Leprology · 2023
    29. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial EClinicalMedicine · 2021 · 3 citations
    30. Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8‐week randomized, double‐blind, placebo‐controlled clinical study International journal of cosmetic science (Print) · 2021 · 1 citations